|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 3.420 USD | +1.79% |
|
+7.21% | -44.39% |
| 09-09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
| 09-01 | Myriad Genetics Shares Fall After Piper Sandler Downgrade | MT |
| Market Cap | 327M 282M 267M 242M 454M 31.25B 456M 3.17B 1.22B 15.9B 1.23B 1.2B 50.24B | P/E 2026 * |
-2.15x | P/E 2027 * | -2.73x |
|---|---|---|---|---|---|
| Enterprise Value | 278M 240M 227M 206M 386M 26.57B 388M 2.69B 1.04B 13.52B 1.04B 1.02B 42.72B | EV / Sales 2026 * |
0.36x | EV / Sales 2027 * | 0.31x |
| Free-Float |
96.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MYGN | Delayed | |
CBOE
| MYGN | Real-time | |
|
Tradegate
| MYD | Real-time | |
|
Deutsche Boerse AG
| MYD | Delayed | |
|
Börse Stuttgart
| MYD | Delayed | |
|
Boerse Muenchen
| MYD | Real-time |
Last Transcript : Myriad Genetics, Inc.
| 1 day | +1.79% | ||
| 1 week | +7.21% | ||
| Current month | +6.21% | ||
| 1 month | +6.21% | ||
| 3 months | -26.13% | ||
| 6 months | -32.41% | ||
| Current year | -44.39% |
| 1 week | 3.06 |  | 3.42 |
| 1 month | 2.84 | | 3.42 |
| Current year | 2.74 | | 7.15 |
| 1 year | 2.74 | | 8.59 |
| 3 years | 2.74 | | 29.3 |
| 5 years | 2.74 | | 35.31 |
| 10 years | 2.74 | | 50.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samraat Raha
CEO | Chief Executive Officer | 54 | 2025-04-29 |
Benjamin Wheeler
DFI | Director of Finance/CFO | 43 | 2025-08-15 |
Raj Jampa
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
S. Phanstiel
CHM | Chairman | 67 | 2020-03-22 |
Heiner Dreismann
BRD | Director/Board Member | 71 | 2010-06-09 |
Colleen Reitan
BRD | Director/Board Member | 66 | 2019-09-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Tax | General Counsel | -4,398 | 0.0046% | ||
| 8/16/26 | Tax | Chief Financial Officer | -8,761 | 0.0093% | ||
| 6/11/26 | Free | Chief Executive Officer | 3,542 | 0.0038% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.79% | +7.21% | -55.47% | -79.03% | 327M | |
| -1.04% | -2.50% | +177.10% | +371.62% | 21.13B | |
| -1.68% | -5.19% | -39.31% | -23.54% | 9.62B | |
| +3.33% | +9.48% | +425.19% | +42.90% | 8.94B | |
| +1.25% | -2.91% | -28.85% | - | 6.88B | |
| -0.14% | -0.71% | +82.31% | +53.40% | 6.54B | |
| 0.00% | -6.45% | -31.35% | -24.13% | 5.64B | |
| -0.27% | -2.60% | -8.36% | -20.94% | 4.22B | |
| -1.59% | -9.17% | +55.29% | +67.99% | 3.84B | |
| -3.08% | -5.58% | -25.36% | -32.60% | 2.65B | |
| Average | -0.14% | -1.86% | +55.12% | +39.52% | 6.98B | |
| Weighted average by Cap. | -0.22% | -1.98% | +106.32% | +131.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 778M 670M 635M 575M 1.08B 74.31B 1.08B 7.54B 2.9B 37.81B 2.92B 2.86B 119B | 821M 708M 670M 607M 1.14B 78.45B 1.14B 7.96B 3.06B 39.91B 3.08B 3.02B 126B |
| Net income | -143M -123M -117M -106M -199M -13.69B -200M -1.39B -534M -6.97B -538M -526M -22.01B | -106M -91.43M -86.57M -78.47M -147M -10.14B -148M -1.03B -395M -5.16B -399M -390M -16.3B |
| Net Debt | -49M -42.22M -39.97M -36.23M -67.97M -4.68B -68.32M -475M -183M -2.38B -184M -180M -7.53B | -74.14M -63.88M -60.48M -54.82M -103M -7.08B -103M -718M -276M -3.6B -278M -272M -11.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | US$3.420 | +1.79% | 2,552,959 |
| 26-09-10 | US$3.360 | +5.33% | 3,939,770 |
| 26-09-09 | US$3.190 | +0.31% | 966,999 |
| 26-09-08 | US$3.180 | -0.31% | 1,194,567 |
| 26-09-04 | US$3.190 | -1.24% | 806,164 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MYGN Stock
Select your edition
All financial news and data tailored to specific country editions
